On Tuesday, Wave Life Sciences Ltd (NASDAQ: WVE) was 0.36% up from the session before settling in for the closing price of $13.79. A 52-week range for WVE has been $3.50 – $15.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 610.91% over the last five years. When this article was written, the company’s average yearly earnings per share was at -87.71%. With a float of $120.28 million, this company’s outstanding shares have now reached $154.93 million.
The firm has a total of 268 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.04%, operating margin of -75.74%, and the pretax margin is -67.11%.
Wave Life Sciences Ltd (WVE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Wave Life Sciences Ltd stocks. The insider ownership of Wave Life Sciences Ltd is 22.36%, while institutional ownership is 65.92%. The most recent insider transaction that took place on Oct 16 ’24, was worth 2,855,051. In this transaction an insider of this company sold 208,836 shares at a rate of $13.67, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 16 ’24, when Company’s President and CEO sold 90,474 for $15.00, making the entire transaction worth $1,357,110. This insider now owns 268,585 shares in total.
Wave Life Sciences Ltd (WVE) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted 0.07 earnings per share (EPS) during the time that was better than consensus figure (set at -0.18) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.71% per share during the next fiscal year.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
You can see what Wave Life Sciences Ltd (WVE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Analysing the last 5-days average volume posted by the [Wave Life Sciences Ltd, WVE], we can find that recorded value of 1.15 million was better than the volume posted last year of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 24.10%. Additionally, its Average True Range was 0.87.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 82.18%, which indicates a significant increase from 25.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.18% in the past 14 days, which was lower than the 130.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.19, while its 200-day Moving Average is $6.44. Now, the first resistance to watch is $14.02. This is followed by the second major resistance level at $14.20. The third major resistance level sits at $14.50. If the price goes on to break the first support level at $13.54, it is likely to go to the next support level at $13.24. Now, if the price goes above the second support level, the third support stands at $13.06.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are 124,738K outstanding shares of the company, which has a market capitalization of 2.14 billion. As of now, sales total 113,310 K while income totals -57,510 K. Its latest quarter income was 19,690 K while its last quarter net income were -32,920 K.
